Skip to main content
. 2019 Sep 25;147:e278. doi: 10.1017/S0950268819001407

Table 2.

Signs, symptoms and clinical manifestations in different age groups

Clinical symptoms Age < 18
N = 116
Age ⩾ 18
N = 135
P-value
Fever >38 °C 83(72%) 83(62%) 0.09
Cough 66(57%) 111(82%) <0.001
Rhinorrhoea 39(34%) 27(20%) 0.01
Sore throat 14(12%) 24(18%) 0.2
Shortness of breath 19(16%) 70(52%) <0.001
Abdominal pain 25(22%) 11(8%) 0.002
Vomiting 39(34%) 23(17%) 0.002
Diarrhoea 17(15%) 10(7%) 0.06
Vital signs
O2 Saturation (%) 96.0 ± 6.3 91.0 ± 7.3 <0.001
Respiratory rate (per minute) 30.9 ± 13.9 23.5 ± 12.1 0.09
Systolic blood pressure (mmHg) 105.6 ± 14.6 124.3 ± 23.3 <0.001
Diastolic blood pressure (mmHg) 63.7 ± 13.0 72.7 ± 13.7 <0.001
Laboratory tests
Leucocytes (1000/μl) 9.2 ± 6.5 7.9 ± 4.6 0.08
Lymphocytes (1000/μl) 2.5 ± 3.1 1.2 ± 2.8 0.001
Platelets (1000/μl) 256.9 ± 145.6 194.6 ± 70.1 <0.001
Neutrophils (%) 62.6 ± 19.1 78.1 ± 10.9 <0.001
Haemoglobin (g/dl) 12.1 ± 1.6 12.6 ± 2.1 0.05
Complications
Pneumonia 6(5%) 49(36%) <0.001
Respiratory failure 2(2%) 8(6%) 0.09
Pleural effusion 1(1%) 8(6%) 0.03
Shock 4(4%) 5(4%) 0.9
Intensive care admission 8(7%) 10(7%) 0.9
Intubation and mechanical ventilation 5(4%) 7(5%) 0.7
Mortality 3(3%) 3(2%) 0.8
Hospitalisation
Symptom duration prior to admission (days) 3.5 ± 3.1 3.9 ± 6.1 0.5
Antiviral treatment 97(84%) 129(96%) 0.002
Symptom duration prior to treatment (days) 3.6 ± 3.0 3.7 ± 6.3 0.1
Hospitalisation duration (days) 3.2 ± 4.4 4.9 ± 4.7 0.03